Citations (27)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Antoine Malek & Donald R Mattison. (2010) Drug development for use during pregnancy: impact of the placenta. Expert Review of Obstetrics & Gynecology 5:4, pages 437-454.
Read now
Read now
Articles from other publishers (26)
Duarte André Ferreira, Filipa Taborda, Teresa Mendonça & Fátima Farinha. (2022) Pregnancy and lactation-associated osteoporosis in a Systemic Lupus Erythematosus patient. Lupus 31:14, pages 1829-1833.
Crossref
Crossref
Abraham Yair Lujano-Negrete, Martha Cecilia Rodríguez-Ruiz, Cassandra Michele Skinner-Taylor, Lorena Perez-Barbosa, Jesus Alberto Cardenas de la Garza, Pedro Alberto García-Hernández, Luis Gerardo Espinosa-Banuelos, Luz Fernanda Gutierrez-Leal, Sofia Jezzini-Martínez & Dionicio Ángel Galarza-Delgado. (2022) Bone metabolism and osteoporosis during pregnancy and lactation. Archives of Osteoporosis 17:1.
Crossref
Crossref
Alexander M. Friedman. (2021) Obstetric venous thromboembolism prophylaxis, risk factors and outcomes. Current Opinion in Obstetrics & Gynecology 33:5, pages 384-390.
Crossref
Crossref
Alexander M. Friedman & Mary E. D’Alton. (2021) Expert review: prevention of obstetrical venous thromboembolism. American Journal of Obstetrics and Gynecology 225:3, pages 228-236.
Crossref
Crossref
Rahul Gupta, Aaqib H Malik, Purva Ranchal, Wilbert S. Aronow, Apurva V. Vyas, Yasotha Rajeswaran, Joanne Quinones & Amy M. Ahnert. (2021) Valvular Heart Disease in Pregnancy: Anticoagulation and the Role of Percutaneous Treatment. Current Problems in Cardiology 46:3, pages 100679.
Crossref
Crossref
Alexander M. Friedman & Mary D’Alton. (2021) Society for Maternal-Fetal Medicine Consult Series #51: thromboembolism prophylaxis for cesarean delivery. American Journal of Obstetrics and Gynecology 224:2, pages 243-244.
Crossref
Crossref
Molly M. Daughety, Jevgenia Zilberman-Rudenko, Joseph J. Shatzel, Owen J. T. McCarty, Vikram Raghunathan & Thomas G. DeLoughery. (2020) Management of Anticoagulation in Pregnant Women With Mechanical Heart Valves. Obstetrical & Gynecological Survey 75:3, pages 190-198.
Crossref
Crossref
Sarah Gloria Običan & Jerome Yankowitz. 2018. Critical Care Obstetrics. Critical Care Obstetrics
151
174
.
Yong-Whee BahkYong-Whee Bahk. 2017. Combined Scintigraphic and Radiographic Diagnosis of Bone and Joint Diseases. Combined Scintigraphic and Radiographic Diagnosis of Bone and Joint Diseases
331
348
.
Christina V. OlesonChristina V. Oleson. 2017. Osteoporosis Rehabilitation. Osteoporosis Rehabilitation
165
192
.
Muhammet Zeki GÜLTEKİN, Ender ALAGÖZ, Serdar YÜKSEL, Şule ÖZSOY, Ali AVCI, Mehmet Akif GÜLEÇ & Oğuz UĞUR. (2016) RİVAROKSABAN VE FARKLI ANTİKOAGÜLANLARIN KIRIK KAYNAMASI ÜZERİNE ETKİLERİNİN BİR RAT MODELİNDE KARŞILAŞTIRILMASICOMPARISON OF RIVAROXABAN AND DIFFERENT ANTICOAGULANTS ON BONE UNION IN A RAT MODEL. Adıyaman Üniversitesi Sağlık Bilimleri Dergisi 2:3, pages 310-322.
Crossref
Crossref
Florence Parent, Philippe Deruelle, Olivier Sanchez, Guy Meyer, Philippe Girard, Fadia Jilwan, Catherine Boyer-Neumann, Martine Wolf & Gerald Simonneau. (2015) Safety of Therapeutic Doses of Tinzaparin During Pregnancy. Gynecologic and Obstetric Investigation 79:4, pages 256-262.
Crossref
Crossref
Pierre Khalifa & Lydia Marie-Scemama. (2013) Héparines de bas poids moléculaire en traitement prolongé au cours de la grossesse : quel risque osseux ?. Therapies 68:1, pages 37-42.
Crossref
Crossref
Yong-Whee BahkYong-Whee Bahk. 2013. Combined Scintigraphic and Radiographic Diagnosis of Bone and Joint Diseases. Combined Scintigraphic and Radiographic Diagnosis of Bone and Joint Diseases
303
317
.
Anita Rajasekhar, Rebecca Beyth & Mark A. Crowther. (2012) Newer Anticoagulants in Critically Ill Patients. Critical Care Clinics 28:3, pages 427-451.
Crossref
Crossref
Sirkku Pollari, Rami S. Käkönen, Khalid S. Mohammad, Jukka P. Rissanen, Jussi M. Halleen, Anni Wärri, Liisa Nissinen, Marjo Pihlavisto, Anne Marjamäki, Merja Perälä, Theresa A. Guise, Olli Kallioniemi & Sanna-Maria Käkönen. (2012) Heparin-like Polysaccharides Reduce Osteolytic Bone Destruction and Tumor Growth in a Mouse Model of Breast Cancer Bone Metastasis. Molecular Cancer Research 10:5, pages 597-604.
Crossref
Crossref
S. Alban. 2012. Heparin - A Century of Progress. Heparin - A Century of Progress
211
263
.
Jérémy Laborderie & Françoise Debiais. (2011) Perte osseuse des traitements anticoagulants. Revue du Rhumatisme Monographies 78:2, pages 119-123.
Crossref
Crossref
Mark Santillan & Jerome Yankowitz. 2010. Critical Care Obstetrics. Critical Care Obstetrics
626
638
.
Daniel S. Weitz & Jeffrey I. Weitz. (2009) Update on heparin: what do we need to know?. Journal of Thrombosis and Thrombolysis 29:2, pages 199-207.
Crossref
Crossref
O Ogueh, M R Johnson & A Benjamin. (2009) A longitudinal study of the effect of heparin thromboprophylaxis during pregnancy on maternal bone metabolism. Obstetric Medicine 2:4, pages 157-160.
Crossref
Crossref
Kanjaksha GhoshShrimati Shetty, Sonal Vora & Vinita Salvi. (2008) Successful Pregnancy Outcome in Women With Bad Obstetric History and Recurrent Fetal Loss Due to Thrombophilia: Effect of Unfractionated Heparin and Low—Molecular Weight Heparin. Clinical and Applied Thrombosis/Hemostasis 14:2, pages 174-179.
Crossref
Crossref
&NA;. (2007) Drugs should be considered potential culprits in patients who present with musculoskeletal disorders. Drugs & Therapy Perspectives 23:10, pages 21-24.
Crossref
Crossref
Bernard Bannwarth. (2007) Drug-Induced Musculoskeletal Disorders. Drug Safety 30:1, pages 27-46.
Crossref
Crossref
. 2007. Combined Scintigraphic and Radiographic Diagnosis of Bone and Joint Diseases. Combined Scintigraphic and Radiographic Diagnosis of Bone and Joint Diseases
303
317
.
N Wiles & B J Hunt. (2016) Anticoagulation via anti-Factor Xa inhibition. Lupus 15:3, pages 167-171.
Crossref
Crossref